Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Ulrich Herrlinger(University of Tübingen), Martin Glas(Essen University Hospital), Horst Urbach(University of Freiburg), Dietmar Krex, Peter Vajkoczy(Humboldt-Universität zu Berlin), Stefanie Brehmer(Montreal Neurological Institute and Hospital), Niklas Schäfer(University Hospital Bonn), Stefan Grau(University of Cologne), Michael Ronellenfitsch(Goethe University Frankfurt), Roland Goldbrunner(University of Cologne), Ralf Kohnen(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sied Kebir(University of Bonn), Astrid Weyerbrock(University of Freiburg), Claus Belka(LMU Klinikum), Oliver Schnell(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter Hau(University Hospital Regensburg), Veit Rohde(Universitätsmedizin Göttingen), H. Maximilian Mehdorn(University Hospital Schleswig-Holstein), Barbara Leutgeb(Goethe University Frankfurt), Jochen Tüttenberg(Goethe University Frankfurt), Rolf‐Dieter Kortmann(University of Turin), Uwe Schlegel(Defence Research and Development Organisation), Moritz Stuplich(University of Bonn), Mathias Hänel(Klinikum Chemnitz), Walter Stummer(University of Münster), Jörg Steinbach(Goethe University Frankfurt), Florian Ringel(Johannes Gutenberg University Mainz), Elmar Dunkl(Goethe University Frankfurt), Michael Sabel(Düsseldorf University Hospital), Martin Proescholdt(University Hospital Regensburg), Franziska Friedrich(Goethe University Frankfurt), Frederic Mack(University of Bonn), Torsten Pietsch, Rüdiger Gerlach(Helios Klinikum Erfurt), Martin Uhl(Friedrich-Alexander-Universität Erlangen-Nürnberg), Regine Mayer‐Steinacker(University Hospital Ulm), Jarek Maciaczyk(University of Bonn)
Cited by 197
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
|New England Journal of Medicine|2017|916